Cell Therapeutics submits Trisenox MAA

CTIC submitted an MAA to the European Agency for the Evaluation of Medicinal Products (EMEA) for its Trisenox arsenic trioxide to treat patients with relapsed acute promyelocytic leukemia (APL). In Se...